Biosimilars LATAM 2015

Key Topics

• Requirements for interchangeability and biosimilarity
• Naming and substitution. Implications and risks
• Current international and local regulation and attempts to reach harmonisation
• Demonstrating biosimilarity in practical terms
• Analysis of the development and commercial factors
• Intellectual property issues
• Current biologics and biosimilars pipeline
• Lessons learned from mature markets
• International regulatory development and approvals
• Main issues behind confidentiality and exchangeability
• Investment opportunities
• Macro analysis and forecast for the biosimilars industry
• Research and development
• State of the art innovation and technologies
• Manufacturing quality and standards
• International partnering and alliances
• Latest trends in biobetters and biosuperiors
• MABs R&D, production and development
• Latest manufacturing technologies and equipment presented through successful case studies
• Latest opportunities and challenges in Latin America

Who should Attend

Representatives from companies and associations related with biologics, biosimilars, biobetters, biotechnology, biotherapeutics.